Fig. 5

hAMSC administration does not affect CD11b⁺CD45⁺ cells in the spleen. A Representative gating strategy for the flow cytometry of CD11b CD45 Ly6C Ly6G cells. Data were obtained from spleen at Days 2, 4 and, 8. B The total cell number. C The number of CD11b⁺CD45⁺ cells. D The number of CD11b⁺CD45⁺Ly6C⁺Ly6G⁻ cells. E The number of CD11b⁺CD45⁺Ly6C⁻Ly6G⁺ cells. Data are plotted in mean ± SEM. P values are based on the Wilcoxon test. *P < 0.05 compared with the ICH group